Using Heart Electrical Signals to Study How Well Treatments Prevent Dangerous Heart Rhythms in Active People
ULTIMATE-A
Utilizing LifeMap To Investigate Malignant Arrhythmia Therapeutic Efficacy in Athletes
2 other identifiers
observational
40
1 country
1
Brief Summary
The goal of this observational study is to learn if two specific heart electrical signal patterns can help in detecting the risk of dangerous heart rhythms in athletes, and to see if exercise-based tests can be used instead of invasive hospital procedures to record this electrical signals. The main questions it aims to answer are:
- 1.Can special ECG action potential duration markers (R2I2 and PERS) identify athletes who are at higher risk of sudden heart rhythm problems.
- 2.Can an exercise test give the same information as a non-invasive electrophysiology study.
- 3.ECG recordings during rest and exercise.
- 4.If they have an ICD or pacemaker, an ECG will be recorded during a non invasive stimulation.
- 5.A continuous 24 hour ECG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2025
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedFirst Posted
Study publicly available on registry
June 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
CompletedJune 11, 2025
June 1, 2025
1.2 years
May 28, 2025
June 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Restitution Markers as Determined by R2I2 and PERS
The primary outcome measure is assessment of changes in the regional restitution instability index and peak ECG restitution slope at various time points including, baseline, during 15-minute exercise and during 15-minute electrophysiology study.
Secondary Outcomes (1)
Non-invasive exercise-based tests correlate with electrophysiology study.
The secondary outcome looks at how the Regional Restitution Instability Index (R2I2) and Peak ECG restitution slope (PERS) measurements during a 15-minute exercise compare with those taken during 15 minute Non-Invasive Programmed Stimulation (NIPS).
Study Arms (3)
Participants with ICD
Those that exercise 3 hours or more per week and/or have a physically active occupation (e.g military, fire service, landscaper, etc.) and have been identified as at risk of sudden cardiac death. Therefore have been implanted with an implantable defibrillator (ICD) for primary or secondary prevention.
Participants without heart device
Those that exercise 3 hours or more per week and/or have a physically active occupation (e.g military, fire service, landscaper, etc.) and do not have any heart condition. Therefore have not been implanted with any heart device.
Participants with Pacemaker
Those that exercise 3 hours or more per week and/or have a physically active occupation (e.g military, fire service, landscaper, etc.) and have not been identified as at risk of sudden cardiac death. Therefore do not have an implantable cardioverter defibrillator, but have been implanted with a cardiac pacemaker due to other conditions.
Eligibility Criteria
Study population will be from a single tertiary care hospital (University Hospitals Leicester), and residents of United Kingdom
You may qualify if:
- Age 18 and over.
- Participates in regular physical activity for at least 3 hours or greater weekly.
- Having Implantable cardioverter defibrillator insitu (cases).
- Having a cardiac pacemaker (control).
- Having no cardiac device (control).
- Sufficient capacity and agreement to participate orally and signed written consent forms.
- Understanding of written and spoken English language.
You may not qualify if:
- Pregnancy, as detected by positive urine pregnancy test result.
- Inability to comply with study protocols.
- Any iatrogenic cardiac pathology (stents, CABG etc).
- Unstable ventricular tachycardia (\>30 seconds).
- Any unstable malignant arrhythmia.
- Fever or presence of a clinically diagnosed febrile illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Glenfield Hospital
Leicester, Leicestershire, LE3 9QP, United Kingdom
Related Publications (2)
Nicolson WB, Smith MI, Vali Z, Samani NJ, Ng GA. Application of two novel electrical restitution-based ECG markers of ventricular arrhythmia to patients with nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2021 Feb;44(2):284-292. doi: 10.1111/pace.14143. Epub 2021 Jan 4.
PMID: 33336815BACKGROUNDNg GA, Mistry A, Li X, Schlindwein FS, Nicolson WB. LifeMap: towards the development of a new technology in sudden cardiac death risk stratification for clinical use. Europace. 2018 Sep 1;20(FI2):f162-f170. doi: 10.1093/europace/euy080.
PMID: 29684162BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ghulam André Ng, MBChB, MRCP, Ph.D, FRCP
University of Leicester, Leicestershire, United Kingdom
- PRINCIPAL INVESTIGATOR
Ghulam André Ng, MBChB, MRCP, Ph.D, FRCP, FHEA
University of Leicester, Leicestershire, United Kingdom
- PRINCIPAL INVESTIGATOR
Xin Li, PhD, MSc, BSc, FHEA
University of Leicester, Leicestershire, United Kingdom
- PRINCIPAL INVESTIGATOR
Harshil Dhutia, MBBS, BSC, MRCP, CCDS, MD(RES)
Glenfield Hospital, Leicester
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2025
First Posted
June 11, 2025
Study Start
June 1, 2025
Primary Completion
July 31, 2026
Study Completion
July 31, 2026
Last Updated
June 11, 2025
Record last verified: 2025-06